Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Arpinati

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Experimental Hematology|February 2, 2002
Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineageFrancesca Re, Mario Arpinati, Nicoletta Testoni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2019
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective StudyAntonio Colecchia, Federico Ravaioli, Mariarosaria Sessa, et al.
Transplantation|October 8, 2005
Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulpLaura Pierdomenico, Laura Bonsi, Mario Calvitti, et al.
Frontiers in Oncology|December 19, 2022
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemiaEnrico Maffini, Margherita Ursi, Francesco Barbato, et al.
Medical Microbiology and Immunology|July 11, 2019
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective studyAngela Chiereghin, Giulia Piccirilli, Tamara Belotti, et al.
Current Opinion in Hematology|December 20, 2022
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantationEnrico Maffini, Moreno Festuccia, Margherita Ursi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2018
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic SyndromesFrancesca Bonifazi, Jacopo Olivieri, Mariarosaria Sessa, et al.
Hepato-Gastroenterology|June 27, 2007
High dose rabbit antithymocyte globulin induction in living related liver transplantationMichele Masetti, Roberto Montalti, Mario Arpinati, et al.
Tumori|February 15, 2020
Health technology assessment-based approach to flow cytometric immunophenotyping of acute leukemias: a literature classificationGiuseppe Gaipa, Eugenio Erba, Marco Danova, et al.
Hematological Oncology|May 26, 2022
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatmentChiara Sartor, Mario Arpinati, Gabriella Chirumbolo, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Experimental Hematology|February 2, 2002
Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineageFrancesca Re, Mario Arpinati, Nicoletta Testoni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2019
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective StudyAntonio Colecchia, Federico Ravaioli, Mariarosaria Sessa, et al.
Transplantation|October 8, 2005
Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulpLaura Pierdomenico, Laura Bonsi, Mario Calvitti, et al.
Frontiers in Oncology|December 19, 2022
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemiaEnrico Maffini, Margherita Ursi, Francesco Barbato, et al.
Medical Microbiology and Immunology|July 11, 2019
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective studyAngela Chiereghin, Giulia Piccirilli, Tamara Belotti, et al.
Current Opinion in Hematology|December 20, 2022
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantationEnrico Maffini, Moreno Festuccia, Margherita Ursi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2018
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic SyndromesFrancesca Bonifazi, Jacopo Olivieri, Mariarosaria Sessa, et al.
Hepato-Gastroenterology|June 27, 2007
High dose rabbit antithymocyte globulin induction in living related liver transplantationMichele Masetti, Roberto Montalti, Mario Arpinati, et al.
Tumori|February 15, 2020
Health technology assessment-based approach to flow cytometric immunophenotyping of acute leukemias: a literature classificationGiuseppe Gaipa, Eugenio Erba, Marco Danova, et al.
Hematological Oncology|May 26, 2022
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatmentChiara Sartor, Mario Arpinati, Gabriella Chirumbolo, et al.
Pageof 6